Hemetron AG

Swiss Rockets is dedicated to developing groundbreaking medicines that transform the treatment of cancer, infectious diseases, and autoimmune disorders – advancing more effective, equitable, and accessible healthcare for patients worldwide.

RC TRITEC is an established company offering custom synthesis of tritium-labeled compounds, a range of tritiated catalog products, storage service and disposal of radiochemicals. We have over 60 years of experience in the safe handling of tritium gas using in-house developed high-vacuum equipment.

Mirava Bio is a Swiss BioCommercial Partner enabling emerging biotechs to bring rare disease & gene therapies to Europe, the Middle East & Eurasia. We define optimal go-to-market strategies and execute via a plug-and-play licensed ready platform, minimizing risk while partners retain control.